Cargando…
Subcutaneous REGEN-COV antibody administration in a community pharmacy
BACKGROUND: REGEN-COV is a non-Food and Drug Adminstration approved monoclonal antibody combination of casirivimab/imdevimab. Casirivimab/imdevimab was previously used for the treatment of SARS-CoV-2 infection (COVID-19), under an emergency use authorization, and has demonstrated a reduction in hosp...
Autores principales: | Dougherty, Tyler S., McBride, Jimmy, Barnett, Carol L., Gabriel, Wendy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824949/ https://www.ncbi.nlm.nih.gov/pubmed/36710148 http://dx.doi.org/10.1016/j.japh.2023.01.002 |
Ejemplares similares
-
Facilitating oral COVID-19 therapy utilization through a pharmacy consult service
por: Portman, David Brennan, et al.
Publicado: (2023) -
Hospital Nuclear Pharmacy Survey: Preliminary Aspects In Brazil
por: Brasil, Marcelo Pau, et al.
Publicado: (2012) -
Assessment of Self-Medication Practices Among Medical, Pharmacy, and Health Science Students in Gondar University, Ethiopia
por: Abay, S M, et al.
Publicado: (2010) -
Patient-physician Communication Barrier: A Pilot Study Evaluating Patient Experiences
por: Khan, TM, et al.
Publicado: (2011) -
In vivo and In vitro Drug Interactions Study of Glimepride with Atorvastatin and Rosuvastatin
por: Galani, VJ, et al.
Publicado: (2010)